
Thomas Seisen
@thoseisen
ID: 2438215248
11-04-2014 09:16:45
300 Tweet
477 Followers
456 Following

Hot off the press in Current Oncology!🔥 An ecological study in 🇺🇸 examining the association between trends in #tobacco smoking prevalence 🚬 and bladder versus lung #Cancer incidence ➡️Check out the full paper mdpi.com/1718-7729/30/2… Brigham and Women's Hospital Department of Urology Dana-Farber Lank Center for Genitourinary Oncology CSPH



Robotic vs open cystectomy with ileal conduit for the management of neurogenic bladder: a comparative study. #BeyondTheAbstract on UroToday > bit.ly/3QkKnlK Ugo Pinar Morgan Roupret Véronique Phé Christophe Vaessen chartier-kastler e Thomas Seisen @WJUrol



On the heals of the Journal of Clinical Oncology Coleman et al. NAC in UTUC trial published earlier this year, Thomas Seisen highlighting the phase 2 iNDUCT at #EAU23 UroToday.com


State-of-the-Art Lecture: Evidence for neoadjuvant treatment before radical nephroureterectomy. Presented by Thomas Seisen Hôpital Pitié-Salpêtrière AP-HP. #EAU23 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3YVg2Nj European Association of Urology (EAU)


Day 2 of #EAU23 was filled with excellent presentations from pioneers in the field of bladder cancer and UTUC. Informative and inspiring! Ashish M. Kamat, MD, MBBS 💙alison birtle Thomas Seisen Arnulf Stenzl Shahrokh F. Shariat jim catto Morgan Roupret Tahlita Zuiverloon MD PhD and more...European Association of Urology (EAU)


🤩Stellar presentation by Ugo Pinar about long term of adjustable ACT balloon at the #EAU23 Main results at 5 years: -62% continence -20% erosion Strong study with long FU chartier-kastler e Morgan Roupret Thomas Seisen Hôpital Pitié-Salpêtrière AP-HP @MedecineSU ruggiero marina


Great presentation by Paolo Gontero on the collaborative effort on BCG Failure by European Association of Urology (EAU) guidelines NMIBC Panel


Current Issue: First-line Intravesical Chemotherapy for Non–muscle-invasive Bladder Cancer: Chimera or “Ne Plus Ultra”? buff.ly/44P1fGW Louis Lenfant Ugo Pinar Morgan Roupret Thomas Seisen #bladdercancer #medtwitter


European Association of Urology (EAU) #eauguidelines meeting for #nmibc #utuc such a great team enjoying Paris after an insightful meeting! Great time-Great thoughts-Great Friends The perfect combo to work during July Alex Masson-Lecomte Paolo Gontero


And a great diner organized by our local 🇫🇷members Evanguelos Xylinas Thomas Seisen Alex Masson-Lecomte 🙏🙏🙏



Should we be using video-recorded cystoscopy for blinded independent central review of tumor response in Open-label NMIBC Trials? Benjamin Pradere Morgan Roupret Thomas Seisen joaquim bellmunt European Urology #bladdercancer sciencedirect.com/science/articl…


Membres #AFU : retrouvez demain à 19h30 un canal AFU dédié à la cystectomie abordant immunothérapie & nouvelles imageries #urologie #vessie. Avec Yann NEUZILLET Constance Thibault Thomas Seisen Merci à notre partenaire Merck France



#NEMIO, a randomized phase I-II trial: Durvalumab +/- tremelimumab in combination with dose-dense MVAC as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma. Presented by Constance Thibault Hôpital européen Georges-Pompidou AP-HP. #ESMO23 coverage by Rashid K. Sayyid > bit.ly/471gbmI


Comparative effectiveness of iRARC vs. ORC for #BladderCancer: findings from a real life study show better perioperative outcomes with similar cancer control and ureteroileal stricture outcomes after iRARC Thomas Seisen doi.org/10.1111/bju.16…


⚡️ Comparative effectiveness of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer #BladderCancer Thomas Seisen BJU International bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

